| Title: | An integrated clinical and genetic model for predicting risk of severe COVID-19: A population-based case-control study |
| Journal: | PLOS ONE |
| Published: | 16 Feb 2021 |
| Pubmed: | https://pubmed.ncbi.nlm.nih.gov/33592063/ |
| DOI: | https://doi.org/10.1371/journal.pone.0247205 |
| URL: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0247205&type=printable |
| Citations: | 32 (14 in last 2 years) as of 8 Aug 2024 |
Publication 4051
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
Abstract
Up to 30% of people who test positive to SARS-CoV-2 will develop severe COVID-19 and require hospitalisation. Age, gender, and comorbidities are known to be risk factors for severe COVID-19 but are generally considered independently without accurate knowledge of the magnitude of their effect on risk, potentially resulting in incorrect risk estimation. There is an urgent need for accurate prediction of the risk of severe COVID-19 for use in workplaces and healthcare settings, and for individual risk management. Clinical risk factors and a panel of 64 single-nucleotide polymorphisms were identified from published data. We used logistic regression to develop a model for severe COVID-19 in 1,582 UK Biobank participants aged 50 years and over who tested positive for the SARS-CoV-2 virus: 1,018 with severe disease and 564 without severe disease. Model discrimination was assessed using the area under the receiver operating characteristic curve (AUC). A model incorporating the SNP score and clinical risk factors (AUC = 0.786; 95% confidence interval = 0.763 to 0.808) had 111% better discrimination of disease severity than a model with just age and gender (AUC = 0.635; 95% confidence interval = 0.607 to 0.662). The effects of age and gender are attenuated by the other risk factors, suggesting that it is those risk factors-not age and gender-that confer risk of severe disease. In the whole UK Biobank, most are at low or only slightly elevated risk, but one-third are at two-fold or more increased risk. We have developed a model that enables accurate prediction of severe COVID-19. Continuing to rely on age and gender alone (or only clinical factors) to determine risk of severe COVID-19 will unnecessarily classify healthy older people as being at high risk and will fail to accurately quantify the increased risk for younger people with comorbidities.</p>
3 Authors
- Gillian S. Dite
- Nicholas M. Murphy
- Richard Allman
Enabling scientific discoveries that improve human health